Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Saba

Showing results (291-300 of 338) with videos related to

Pageof 34
Sort By:
Circulation|November 3, 2004
Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylationHsiao-Huei Chen, Catherine J Baty, Tomoji Maeda, et al.
Journal of Electrocardiology|September 10, 2024
Clinical usability of deep learning-based saliency maps for occlusion myocardial infarction identification from the prehospital 12-Lead electrocardiogramNathan T Riek, Tanmay A Gokhale, Christian Martin-Gill, et al.
JACC. Clinical Electrophysiology|June 27, 2024
Long-Term Changes in Atrial Arrhythmia Burden After Renal Denervation Combined With Pulmonary Vein Isolation: SYMPLICITY-AFLarry Chinitz, Michael Böhm, Rudolph Evonich, et al.
The American Journal of Cardiology|May 14, 2023
Relative Contribution of Atrial Fibrillation to Outcomes of Patients With Cardiomyopathy Based on Severity of Left Ventricular DysfunctionMumammad Talha Ayub, Gautam Rangavajla, Floyd Thoma, et al.
Pacing and Clinical Electrophysiology : PACE|July 15, 2015
Risk of Stroke and Death in Atrial Fibrillation by Type of Anticoagulation: A Propensity-Matched AnalysisGeorge Leef, Dingxin Qin, Andrew Althouse, et al.
Pacing and Clinical Electrophysiology : PACE|May 16, 2018
Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: A systematic review and meta-analysisNorman C Wang, Matthew D Sather, Aliza Hussain, et al.
Circulation. Cardiovascular Quality and Outcomes|August 30, 2021
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care NetworkAnum Saeed, Jianhui Zhu, Floyd Thoma, et al.
Circulation. Arrhythmia and Electrophysiology|March 8, 2019
Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of AmericaJack Z Li, Aditya Bhonsale, N A Mark Estes, et al.
European Heart Journal. Imaging Methods and Practice|May 18, 2026
Prognostic importance of septal deformation patterns and lateral wall function in patients with heart failure and left bundle branch block receiving cardiac resynchronization therapyNiels Risum, Emil Anton Frandsen, Bhupendar Tayal, et al.
Journal of Cardiovascular Electrophysiology|November 6, 2022
Dofetilide use is not associated with increased mortality in patients with left ventricular hypertrophy and atrial fibrillationDaniel G Wann, Brent S Medoff, Noor-Ul-Huda A Mehdi, et al.
Pageof 34

Showing results (291-300 of 338) with videos related to

Sort By:
Pageof 34
Circulation|November 3, 2004
Transcription enhancer factor-1-related factor-transgenic mice develop cardiac conduction defects associated with altered connexin phosphorylationHsiao-Huei Chen, Catherine J Baty, Tomoji Maeda, et al.
Journal of Electrocardiology|September 10, 2024
Clinical usability of deep learning-based saliency maps for occlusion myocardial infarction identification from the prehospital 12-Lead electrocardiogramNathan T Riek, Tanmay A Gokhale, Christian Martin-Gill, et al.
JACC. Clinical Electrophysiology|June 27, 2024
Long-Term Changes in Atrial Arrhythmia Burden After Renal Denervation Combined With Pulmonary Vein Isolation: SYMPLICITY-AFLarry Chinitz, Michael Böhm, Rudolph Evonich, et al.
The American Journal of Cardiology|May 14, 2023
Relative Contribution of Atrial Fibrillation to Outcomes of Patients With Cardiomyopathy Based on Severity of Left Ventricular DysfunctionMumammad Talha Ayub, Gautam Rangavajla, Floyd Thoma, et al.
Pacing and Clinical Electrophysiology : PACE|July 15, 2015
Risk of Stroke and Death in Atrial Fibrillation by Type of Anticoagulation: A Propensity-Matched AnalysisGeorge Leef, Dingxin Qin, Andrew Althouse, et al.
Pacing and Clinical Electrophysiology : PACE|May 16, 2018
Oral anticoagulation and left atrial thrombi resolution in nonrheumatic atrial fibrillation or flutter: A systematic review and meta-analysisNorman C Wang, Matthew D Sather, Aliza Hussain, et al.
Circulation. Cardiovascular Quality and Outcomes|August 30, 2021
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care NetworkAnum Saeed, Jianhui Zhu, Floyd Thoma, et al.
Circulation. Arrhythmia and Electrophysiology|March 8, 2019
Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of AmericaJack Z Li, Aditya Bhonsale, N A Mark Estes, et al.
European Heart Journal. Imaging Methods and Practice|May 18, 2026
Prognostic importance of septal deformation patterns and lateral wall function in patients with heart failure and left bundle branch block receiving cardiac resynchronization therapyNiels Risum, Emil Anton Frandsen, Bhupendar Tayal, et al.
Journal of Cardiovascular Electrophysiology|November 6, 2022
Dofetilide use is not associated with increased mortality in patients with left ventricular hypertrophy and atrial fibrillationDaniel G Wann, Brent S Medoff, Noor-Ul-Huda A Mehdi, et al.
Pageof 34